Gene · 4209
Papers1,497
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,497
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC. | Front Pharmacol | 2024 | 39744125 | PubTator, text mining | PubMed |
| Mef2d: a novel transcription factor in type 2 allergic lung inflammation. | Signal Transduct Target Ther | 2024 | 39511156 | PubTator, text mining | PubMed |
| Sodium Tungstate Promotes Neurite Outgrowth and Confers Neuroprotection in Neuro2a and SH-SY5Y Cells. | Int J Mol Sci | 2024 | 39273113 | PubTator, text mining | PubMed |
| Oral Piwi-Interacting RNA Delivery Mediated by Green Tea-Derived Exosome-Like Nanovesicles for the Treatment of Aortic Dissection. | Adv Healthc Mater | 2024 | 39087398 | PubTator, text mining | PubMed |
| The Molecular and Biological Function of MEF2D in Leukemia. | Adv Exp Med Biol | 2024 | 39017853 | PubTator, text mining | PubMed |
| Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements. | Ann Hematol | 2024 | 38990294 | PubTator, text mining | PubMed |
| Mef2d potentiates type-2 immune responses and allergic lung inflammation. | Science | 2024 | 38935708 | PubTator, text mining | PubMed |
| Identification of a novel MEF2C::SS18L1 fusion in childhood acute B-lymphoblastic leukemia. | J Cancer Res Clin Oncol | 2024 | 38907739 | PubTator, text mining | PubMed |
| The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer. | Aging (Albany NY) | 2024 | 38888512 | PubTator, text mining | PubMed |
| The roles of nuclear orphan receptor NR2F6 in anti-viral innate immunity. | PLoS Pathog | 2024 | 38829910 | PubTator, text mining | PubMed |
| Transcriptional regulation of Tfh dynamics and the formation of immunological synapses. | Exp Mol Med | 2024 | 38825646 | PubTator, text mining | PubMed |
| MEF2D Functions as a Tumor Suppressor in Breast Cancer. | Int J Mol Sci | 2024 | 38791246 | PubTator, text mining | PubMed |
| MEF2D facilitates liver metastasis of gastric cancer cells through directly inducing H1X under IL-13 stimulation. | Cancer Lett | 2024 | 38609001 | PubTator, text mining | PubMed |
| Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia. | Pathol Res Pract | 2024 | 38579576 | PubTator, text mining | PubMed |
| Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA. | J Mol Biol | 2024 | 38492719 | PubTator, text mining | PubMed |
| Targeting histone deacetylase 9 represses fibrogenic phenotypes in buccal mucosal fibroblasts with arecoline stimulation. | J Dent Sci | 2024 | 38303807 | PubTator, text mining | PubMed |
| Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers. | Clin Exp Med | 2024 | 38294554 | PubTator, text mining | PubMed |
| In Utero Origins of Acute Leukemia in Children. | Biomedicines | 2024 | 38275407 | PubTator, text mining | PubMed |
| Correction: Samak et al. Dysregulation of Krüppel-like Factor 2 and Myocyte Enhancer Factor 2D Drive Cardiac Microvascular Inflammation and Dysfunction in Diabetes. Int. J. Mol. Sci. 2023, 24, 2482. | Int J Mol Sci | 2024 | 38256279 | PubTator, text mining | PubMed |
| Vitamin D receptor induces oxidative stress to promote esophageal squamous cell carcinoma proliferation via the p53 signaling pathway. | Heliyon | 2024 | 38234882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4209/papers?page=4